Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Ultragenyx Pharmaceutical

Biotech & Life Sciences · Novato, United States · Founded 2010 · IPO 2014 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.73B
Market cap · Apr/2026
Revenue
$673M
Latest reported FY

Investors

7 investors on Ultragenyx Pharmaceutical's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
Takeda Ventures
TPG
Series B+ 5 investors entered at this stage
HealthCap
Pappas Capital
F-Prime
TPG Growth
RA Capital Management

Global footprint

Where Ultragenyx Pharmaceutical has talent and traffic

AI talent share
0.1% of workforce is AI talent
(1 of 1,533 staff)
Core AI00%
Other AI10.07%
Non-AI workforce1,53299.93%
Web traffic by country
46K monthly visits
across markets
🇺🇸 United States55.7%
🇮🇳 India6.5%
🇯🇵 Japan5.4%
🇬🇧 United Kingdom4.3%
🇲🇽 Mexico3.9%
Top 5 markets shown

Patent intelligence

$79M patent portfolio · 49 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$79M
4.6% of market cap · 34.5× smaller than top peer Illumina ($2.7B)
49 active patent families
Where Ultragenyx Pharmaceutical innovates Adeno-associated virusMolecular biologyVirusSialic acidBioinformatics
Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

Ultragenyx Pharmaceutical on the five Patsnap quality dimensions

Ultragenyx Pharmaceutical in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Ultragenyx Pharmaceutical concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Ultragenyx Pharmaceutical and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Ultragenyx Pharmaceutical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo